Mattias Andersson - Kinnevik Investment General Secretary
| 0RH1 Stock | 76.10 0.75 1.00% |
Executive
Mattias Andersson is General Secretary of Kinnevik Investment AB
| Age | 48 |
| Address | Skeppsbron 18, Stockholm, Sweden, 103 13 |
| Phone | 46 8 56 20 00 00 |
| Web | https://www.kinnevik.com |
Kinnevik Investment Management Efficiency
The company has return on total asset (ROA) of (0.0961) % which means that it has lost $0.0961 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1597) %, meaning that it generated substantial loss on money invested by shareholders. Kinnevik Investment's management efficiency ratios could be used to measure how well Kinnevik Investment manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Kinnevik Investment's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 70.4 B in 2024, despite the fact that Other Assets are likely to grow to (9.1 B).Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Sergey Yeskov | Molson Coors Beverage | 47 | |
| Traci Mangini | Molson Coors Beverage | 54 | |
| Kevin Langridge | Futura Medical | N/A | |
| Helge Wei | CompuGroup Medical AG | N/A | |
| Nigel Wright | Spirent Communications plc | N/A | |
| Rahul Goyal | Molson Coors Beverage | N/A | |
| Jim Klaassen | Spirent Communications plc | N/A | |
| Sofia Colucci | Molson Coors Beverage | N/A | |
| Adam Collins | Molson Coors Beverage | N/A | |
| Dave Osswald | Molson Coors Beverage | N/A | |
| Tracey Joubert | Molson Coors Beverage | 57 | |
| William Potter | Futura Medical | 76 | |
| Emanuele Mugnani | CompuGroup Medical AG | 54 | |
| AnneMarie DAngelo | Molson Coors Beverage | 47 | |
| Hannes Reichl | CompuGroup Medical AG | 48 | |
| Angus Iveson | Spirent Communications plc | N/A | |
| Brian Erhardt | Molson Coors Beverage | N/A | |
| Michelle Jacques | Molson Coors Beverage | 46 | |
| Eckart Pech | CompuGroup Medical AG | 55 | |
| Daniela Hommel | CompuGroup Medical AG | 49 | |
| Alexander Weimer | CompuGroup Medical AG | N/A | |
Management Performance
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0961 |
Kinnevik Investment Leadership Team
Elected by the shareholders, the Kinnevik Investment's board of directors comprises two types of representatives: Kinnevik Investment inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kinnevik. The board's role is to monitor Kinnevik Investment's management team and ensure that shareholders' interests are well served. Kinnevik Investment's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kinnevik Investment's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Georgi Ganev, Chief Officer | ||
| Mathew CPA, Sustainability Director | ||
| Anna Stenberg, Chief Officer | ||
| Magnus Jakobson, Capital Director | ||
| Samuel Sjostrom, Chief Officer | ||
| Mattias Andersson, General Secretary | ||
| Christopher Bischoff, Investment Director | ||
| Christian Scherrer, Investment Director | ||
| Natalie Tydeman, Investment Director | ||
| Tatiana Shalalvand, Investment Director | ||
| Ola Nordbye, Investment Director | ||
| Andreas Bernstrom, Investment Director | ||
| Torun Litzen, Director Communications | ||
| Akhil Chainwala, Investment Investor |
Kinnevik Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kinnevik Investment a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0961 | |||
| Operating Margin | 1.06 % | |||
| Current Valuation | 9.28 B | |||
| Shares Outstanding | 275.13 M | |||
| Shares Owned By Insiders | 0.46 % | |||
| Shares Owned By Institutions | 57.48 % | |||
| Price To Sales | 10.11 X | |||
| Revenue | (4.72 B) | |||
| Gross Profit | (19.32 B) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Kinnevik Stock Analysis
When running Kinnevik Investment's price analysis, check to measure Kinnevik Investment's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kinnevik Investment is operating at the current time. Most of Kinnevik Investment's value examination focuses on studying past and present price action to predict the probability of Kinnevik Investment's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kinnevik Investment's price. Additionally, you may evaluate how the addition of Kinnevik Investment to your portfolios can decrease your overall portfolio volatility.